In March 2022 the Company submitted a proposal to the USA Food and Drug Administration (FDA) ....... A response is expected shortlyand, once received, the Company will be in a position to determine its capital requirements from potential partners and non-equity funding sources.
BIT hit a 52 wk high last Friday bon volume. It is coming off a loooong basing pattern. These can provide explosive SP moves.
FDA and funding news ( which must be imminent ) will send BIT into the stratosphere. .....Like...ten bagger territory IMO.
